-
Seventeen UK firms adopt four-day week after successful trial. The six-month trial led by the 4 Day Week Foundation showed improvements in staff wellbeing and productivity, prompting 12 companies to adopt a permanent four-day week and five to implement a “nine-day fortnight”.
-
Frasers Group secures £3.5bn financing for growth and acquisitions. The new package replaces existing loans, enhancing Frasers’ financial strength for future expansion. The facility underscores banking support for its strategy, positioning it well for market opportunities.
-
The EU has launched a five-pillar quantum plan. The Commission wants Europe to become a “quantum industrial powerhouse” by 2030 — and is drawing up a Quantum Act to boost investment, secure infrastructure, and scale start-ups. Six pilot chip lines and a new quantum academy will launch by 2026.
-
Rachel Reeves cried during PMQs. That wasn’t a weakness. The Chancellor’s tearful moment in Parliament opens a deeper conversation about how vulnerability is reshaping the expectations — and impact — of modern leadership.
-
Greggs predicts lower profits due to reduced footfall and sales. The bakery chain’s shares fell over 13% after June’s heatwave. Analysts cite slow sales and rising costs as contributing factors to the expected profit decline.
-
New data rules reshape marketing compliance and campaign design. The DUAA brings clarity to cookie consent, lawful bases, and direct marketing — with specific implications for CRM, analytics, and digital strategy.
-
Tariff fears are delaying Bank of England action. Governor Andrew Bailey warned that global trade uncertainty is paralysing investment, making it harder to cut interest rates without deepening the slowdown. The Bank now faces a slower, cautious path to easing.
-
Santander UK acquires TSB in a £2.9bn landmark deal. The acquisition will expand Santander’s market share, adding five million customers and £69bn in assets. The deal, expected to close in early 2026, awaits regulatory approval.
-
UK directors are facing a new phase of economic uncertainty. Confidence remains fragile amid tax increases, labour cost hikes, and regulatory change — with small firms and long-term sectors feeling the strain.
-
AstraZeneca chief hints at US move, intensifying pressure on UK markets. The FTSE 100’s largest company may relocate its primary stock listing to New York, as its CEO signals strategic realignment.